FINWIRES · TerminalLIVE
FINWIRES

REA Group's ACCC Undertaking to Have Benign Impact on Earnings, Jefferies Says

By

REA Group's (ASX:REA) undertaking with the Australian Competition and Consumer Commission (ACCC) to resolve concerns over its subscription offerings will have only a benign impact on the company's earnings, Jefferies said in a Monday note.

"Positively, there is no price regulation from the ACCC and the announcement today removes any overhang on the stock," the investment firm said.

As part of the agreement with the regulator, agencies covered by premium depth contracts must be given the flexibility to downgrade at least 25% of their listings to lower tiers from January 2027. However, Jefferies believes the extent of downgrades will probably be very limited given the value REA delivers to agents and vendors.

"As long as REA can demonstrate that it is delivering the highest number and quality of leads, it would be able to command a premium price and encourage vendors (through agents) to take up depth listings and potentially add-on products like Luxe and Audience Maximiser," the equity research firm said.

Additionally, REA can no longer require agencies to list all or the majority of their properties on realestate.com.au. But this element of the undertaking relates to subscriptions and not the depth contracts, so it will likely have no impact on the company's listings volume, Jefferies added.

The investment firm has a buy rating on REA Group with a price target of AU$195.

What else is happening in Asia?

Asia

GenFleet Presents Updated Lung Cancer Therapy Data at Korean Medical Conference

GenFleet Therapeutics (HKG:2595) said Tuesday it presented the updated Phase 2 data for GFH375 monotherapy in pretreated KRAS G12D-mutant non-small cell lung cancer at the World Conference on Lung Cancer in South Korea.The company said the updated results showed an objective response rate of 59.2%, a disease control rate of 93%, and a 12-month overall survival rate of 77% in 71 subjects who received 600 milligrams of the oral drug, according to a Tuesday disclosure.

HKG:2595
Asia

White Cliff Minerals Says Gina Rinehart's Hancock Prospecting to Take 13.5% Stake With Nearly AU$9 Million Investment

White Cliff Minerals (ASX:WCN) said Hancock Prospecting agreed to acquire a 13.5% stake in the company through the purchase of about 515.8 million new shares at AU$0.017 each, representing a total investment of roughly AU$8.8 million, according to a Tuesday filing with the Australian bourse.Mining magnate Gina Rinehart is the executive chair of Hancock Prospecting.The private placement is subject to shareholder approval, which White Cliff Minerals will seek at an extraordinary general meeting planned for Oct. 19.If approval is obtained, the completion of the placement is expected three business days after the meeting, per the filing.White Cliff Minerals said it will use the proceeds to expand and fast-track drilling and exploration activities at its Rae copper project in Canada.

ASX:WCN
Asia

Wafangdian Bearing Seeks Delisting As Public Float Falls Below 10%

Wafangdian Bearing (SHE:200706) is looking to terminate its stock listing in Shenzhen following a tender offer, according to a Tuesday filing with the Shenzhen bourse.Up to 1,459 shareholders accepted the tender offer as of Feb. 27, 2026, the bearing manufacturer said in its filing.Following the tender offer, the public float fell to below 10%, falling short of the minimum float required to remain listed, Wafangdian said.

SHE:200706